Francis Duhay, Director at enVVeno Medical Corp (NVNO), sold 4,900 shares at $0.36 ($2K) on 2025-12-11, disclosed to the SEC on 2025-12-12.
Scheduled sale ($2k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| NVNO | SELL | 2026-03-13 | $3K | — | Filing → |
| NVNO | SELL | 2025-09-17 | $4K | — | Filing → |
| NVNO | BUY | 2025-01-03 | $500K | — | Filing → |